|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22,850.00 KRW | +6.78% |
|
-9.33% | -46.24% |
| 06-08 | Alligator partner Henlius doses first patients in HLX22 study | FW |
| 05-22 | Alligator Bioscience comments on Henlius update for HLX22 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 287M | - | - | - | - | - |
| 66.75B | |||||
| 50.65B | |||||
| 42.55B | |||||
| 41.15B | - | ||||
| 28.34B |
- Stock Market
- Stocks
- A174900 Stock
- Charts AbClon Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
